By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Grifols 

4560 Horton Street

Emeryville  California  94608  U.S.A.
Phone: 510-655-8730 Fax: n/a


SEARCH JOBS

Grifols is a global healthcare company celebrating more than 75 years of improving the health and well-being of people around the world. An experienced and trusted partner, the Grifols Diagnostic Division advances patient care with innovative solutions that improve disease detection and management and simplify laboratory operations. We empower customers with diagnostic products that span the healthcare continuum – from prevention, screening, diagnosis, and prognosis to disease and treatment monitoring.

Our comprehensive Transfusion Medicine portfolio is designed to support safety from donation through transfusion. We also offer a growing portfolio of specialized clinical diagnostics designed to detect and monitor treatment of infectious, autoimmune, and neurodegenerative diseases.



Key Statistics


Email:
Ownership: Public

Web Site: Grifols
Employees: 14,700
Symbol: GRFS
 



Industry
Healthcare






Company News
Grifols (GRFS) Opens Diagnostic Training Center In Dubai 9/6/2016 8:20:22 AM
FDA Approves Use Of The Procleix Zika Virus Assay From Hologic (HOLX) And Grifols (GRFS) To Screen The U.S. Blood Supply Under An IND Study Protocol 6/20/2016 6:40:00 AM
Grifols (GRFS) To Install The Kiro Oncology Robot At Smilow Cancer Hospital 6/10/2016 8:50:11 AM
Grifols (GRFS) Coughs Up $50 Million for a 20% Stake in Singulex 5/31/2016 7:54:31 AM
Grifols (GRFS) 2015 Annual Report On Form 20-F Filed With The SEC On April 5, 2016 4/5/2016 6:35:39 AM
Lurie Children’s Hospital Selects Grifols (GRFS) KIRO Robot To Increase Precision, Safety, And Compliance Of Pediatric IV Chemotherapy Handling And Compounding 3/23/2016 9:58:40 AM
Grifols (GRFS) 2014 Annual Report On Form 20-F Filed With The SEC On April 1, 2015 4/1/2015 6:05:09 AM
Plasma Medication Manufacturer Grifols Opens State-Of-The-Art Facility In North Carolina, 200 New Jobs On The Horizon 6/17/2014 11:13:20 AM
Grifols Completes Patient Enrollment In Its Phase2/3 Psoriasis Trial; Final Results Are Expected In Q1 2015 6/17/2014 10:50:26 AM
TiGenix: Appoints Gri-Cel CEO Dirk Buscher And COO Jose Terencio To Board Of Directors Following Strategic Investment By Grifols 12/5/2013 9:36:31 AM
123456
//-->